ロード中...
A Double-Blind Placebo-Controlled Comparison of a Novel Formulation of Intravenous Diclofenac and Ketorolac for Postoperative Third Molar Extraction Pain
Dyloject is a novel formulation of diclofenac intended for intravenous (IV) administration. This formulation employs the solubilizing agent hydroxypropyl-β-cyclodextrin to permit bolus IV administration. The efficacy and safety of 5 dose levels of IV diclofenac were compared with IV ketorolac and pl...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Dental Society of Anesthesiology
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3198130/ https://ncbi.nlm.nih.gov/pubmed/21679043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2344/0003-3006-58.2.73 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|